Candesant Biomedical secures £35m to further commercialise Brella SweatControl Patch
Brella received clearance from the US Food and Drug Administration (FDA) in April this year for the management…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Jun 23
Brella received clearance from the US Food and Drug Administration (FDA) in April this year for the management…
21 Mar 23
As the first-ever compostable tea wrapper to be certified by the BPI, the packaging meets stringent standards for…
01 Jul 21
XIENCE Skypoint is the latest among XIENCE family stents, approved in the US and Europe, with a shorter…
08 Jun 21
SenSight has recently received CE Mark to enable patient-specific DBS therapy for symptoms related to movement disorders
19 May 21
The new manufacturing facility for drug delivery devices will employ 150 people in 2024 and up to 600…
06 Apr 21
The US regulator indicated ProSense for the treatment of T1 invasive breast cancer and breast cancer for patients…
21 Oct 20
The 12-month data from RCT shows 84% back pain responder rate and 69% profound responder rate for Intellis…
16 Jul 20
Medicrea is engaged in designing, integrated manufacturing and distribution of implant technologies for use in spinal surgeries